Another amazing blog, Fabi! Always a pleasure working with you 🥰

🙌🏼

Want to learn more? Read the blog!
buff.ly/WWGE3Qz
It's an evidence-based summary of this new paper, written by an expert who has critically appraised the research so you don't have to. All blogs are short (1,200 words) & easy to read, so ideal if you just have a few mins.

This is where research into immune cell subtypes and functions becomes critical.

Instead, they suggest a need to refine how and when we target the immune system – perhaps focusing on early stages of psychosis or treatment-resistant individuals and the need to use more precise immune phenotyping to guide intervention.

From a clinical standpoint, these findings are not a call to start prescribing anti-inflammatory drugs, especially given the disappointing results from previous trials using broad immunomodulators.

This meta-analysis by Dudeck et al. (2025) reinforces the growing consensus that immune dysfunction plays a role in schizophrenia, particularly early in the illness and in unmedicated patients. But what does this mean for clinical practice?

Dr Fabiana Corsi-Zuelli @fabicz.bsky.social discusses the differences in immune cell counts in patients with schizophrenia compared to controls.

Another great piece of work with @eimearfoley.bsky.social 👏🏽